Vexim brings in financial expertise in-house for expansion
This article was originally published in Clinica
French spinal technology firm Vexim has appointed Jérôme Marzinski deputy CEO. Mr Marzinski has a solid background in finance and within medtech; he has worked for vascular implants firm ev3, where he joined as international finance manager and was then promoted to European general manager. Following the acquisition of ev3 by Covidien and prior to joining Vexim, Mr Marzinski worked as a medtech consultant. He will report to the CEO of Vexim, Vincent Gardès. The Toulouse-based company is ramping up European commercialization of its SpineJack minimally invasive device for treating vertebral compression fractures.